Promising combo for advanced melanoma trial halted early
Disease control
Terminated
This study tested a combination of two drugs, cabozantinib and pembrolizumab, as a first treatment for people with advanced melanoma that had spread. The goal was to see if the combination was safe and could shrink tumors. The trial was stopped early, but the results help guide f…
Phase: PHASE1, PHASE2 • Sponsor: John Rieth • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC